In addition, Zhang et al. demonstrated that AKR1C2 could act as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway. This evidence concerns the gene AKR1C2 and esophageal squamous cell carcinoma.